Transplant drug warning after medication errorsGP onlineTacrolimus has a narrow therapeutic index, meaning even small differences in blood levels can cause transplant rejection or lead to adverse reactions, the CHM said. In a letter to health professio…
Why belly fat isn't all badScience Daily (press release)Transplant rejection · Natural killer cell · T cell · Immune system. But Loyola University Chicago Stritch School of Medicine researchers have found that the …
Dividend.comPositive long-term results for Bristol-Myers Squibb's Nulojix in organ rejectionThe Pharma LetterNulojix was approved by both US and European regulators last summer for the prevention of acute rejection in adult patients who have had a …
Kids' Kidneys Can Work Well in Adult RecipientsRenal and Urology NewsThe acute rejection rate at one year was 4%. The investigators concluded that transplant surgeons should be encouraged to use child donor kidneys, which frequently are discarded. …
Adult stem cells: Big benefit, no controversyBethany Beach WaveThe second would also eliminate the need for any required transplant rejection medications since the adult stem cells being used would come from your own body. While the use of adult stem c…
Top Losers in After-hours Today, Jun-1Fyxnews… Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplant rejection, cancer…
Insiders Sold These Stocks on May-31FyxnewsAlexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplan…
/C O R R E C T I O N — Veloxis Pharmaceuticals A/S/Sacramento BeeThis subgroup analysis suggests that African Americans experience similar clinical results on LCP-Tacro, once-daily, as with twice-daily tacrolimus and there is evidence to suggest a low…
Some Top-Rated Stocks Set Up As Market FallsInvestor’s Business DailyAlexion Pharmaceuticals (ALXN), whose specialty is treatments for cancer, auto-immunity disorders and transplant rejection, has built a 10-week base. The base shows a correction of ju…
Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of …MarketWatch (press release)This subgroup analysis suggests that African Americans experience similar clinical results on LCP-Tacro, once-daily, as with twice-daily tacrol…